Related Experiment Video

Updated: Sep 28, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

[Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant

Qiu-li Li1, Fu-jing Chen

  • 1Department of Head & Neck, Cancer Center, Sun Yat-sen University, Guangzhou 510060, P. R. China. Liq99@163.net

AI Zheng = Aizheng = Chinese Journal of Cancer
|November 28, 2002
PubMed

Insights

Vascular Endothelial Growth Factor-C (VEGF-C) and VEGF-D are key drivers of malignant tumor lymph node metastasis. This review covers their roles and strategies for inhibiting this dangerous cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Context:

  • Lymph node metastasis is a critical factor in cancer progression and patient prognosis.
  • Understanding the molecular mechanisms driving metastasis is essential for developing effective treatments.

Purpose:

  • To review the structure, function, and mechanisms of VEGF-C and VEGF-D in lymph node metastasis.
  • To summarize current strategies for inhibiting VEGF-C and VEGF-D mediated metastasis.

Summary:

  • Vascular Endothelial Growth Factor-C (VEGF-C) and Vascular Endothelial Growth Factor-D (VEGF-D) play significant roles in promoting tumor spread to lymph nodes.
  • These growth factors influence lymphangiogenesis and vascular permeability, facilitating cancer cell intravasation and transport.
  • Research is exploring targeted therapies to inhibit VEGF-C and VEGF-D signaling pathways to prevent or reduce lymph node metastasis.

Impact:

  • Provides a comprehensive overview of VEGF-C and VEGF-D in metastasis for researchers and clinicians.
  • Highlights potential therapeutic targets for controlling cancer spread.
  • Informs the development of novel anti-metastatic strategies focusing on inhibiting lymphangiogenesis and metastasis.

More Related Videos

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...